Search by First Name and/or Last Name. Results are displayed in descending publication year and then sorted ascending by the reference field. Need to submit a publication reference?
Name: Anne Fagan
Year: 2011
Reference:
Perrin R, Craig-Schapiro R, Malone J, Shah A, Gilmore P, Davis A, Roe C, Peskind E, Li G, Galasko D, Clark C, Quinn J, Kaye J, Morris J, Holtzman D, Townsend R, Fagan AM. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer’s disease. PLoS One, 2011; 6:e16032. PMID: 21264269
Name: Catherine Roe
Year: 2011
Reference:
Perrin RJ, Craig-Shapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, Roe CM, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, Kaye JA, Morris JC, Holtzman DM, Townsend RR, Fagan AM. Identification and validation of novel cerebrospinal fluid biomarkers of staging early Alzheimer’s disease. PLoS ONE 2011; 6:e16032 PMCID: PMC3020224
Name: alison goate
Year: 2011
Reference:
Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, Apostolova LG, Barrio JR, Small G, Silverman DH, Siu E, Cederbaum S, Hecimovic S, Malnar M, Chakraverty S, Goate AM, Bird TD, Leverenz JB. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer’s disease due to a novel PSEN1 mutation. Neurosci Lett. 2011; 487(3):287-92. PMCID: PMC3034479
Name: Alison Goate
Year: 2011
Reference:
Ringman JM, Gylys KH, Medina LD, Fox M, Kepe V, Flores DL, Apostolova LG, Barrio JR, Small G, Silverman DH, Siu E, Cederbaum S, Hecimovic S, Malnar M, Chakraverty S, Goate AM, Bird TD, Leverenz JB. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer’s disease due to a novel PSEN1 mutation. Neurosci Lett. 2011; 487(3):287-92. PMCID: PMC3034479
Name: Catherine Roe
Year: 2011
Reference:
Roe CM, Fagan AM, Grant EA, Marcus DS, Benzinger TLS, Mintun MA, Holtzman DM, Morris JC. Cerebrospinal fluid biomarkers, education, brain volume, and future cognition. Archives of Neurology 2011;68:1145-1152. PMCID: PMC3203689.
Name: Anne Fagan
Year: 2011
Reference:
Roe CM, Fagan AM, Grant EA, Marcus DS, Benzinger TLS, Mintun MA, Holtzman DM, Morris JC. Cerebrospinal fluid biomarkers, education, brain volume, and future cognition. Archives of Neurology, 2011, 68:1145-51. PMCID: PMC3203689
Name: Anne Fagan
Year: 2011
Reference:
Roe CM, Fagan AM, Williams MM, Ghoshal N, Aeschleman M, Grant EA, Marcus DS, Mintun MA, Holtzman DM, Morris JC. Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology, 2011, 76:501-10. PMCID: PMC3154969
Name: Catherine Roe
Year: 2011
Reference:
Roe CM, Fagan AM, Williams MM, Ghoshal N, Aeschleman M, Grant EA, Marcus DS, Mintun MA, Holtzman DM, Morris JC. Improving CSF Biomarker Accuracy in Predicting Prevalent and Incident Alzheimer’s Disease. Neurology 2011;76(6):501-510. PMCID: PMC3053181.
Name: Anne Fagan
Year: 2011
Reference:
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia, 2011, 7:280-92. PMCID: PMC3220946
Name: Anne Fagan
Year: 2011
Reference:
Tarawneh R, D’Angelo, G, Macy E, Xiong C, Carter D, Cairns NJ, Fagan AM, PhD, Head D, Mintun MA, Ladenson JH, Lee J-M, Morris JC, Holtzman DM. Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease. Annals of Neurology, 2011, 70:274-85. PMCID: PMC3154071
Name: Lisa Taylor-Reinwald
Year: 2011
Reference:
Tarawneh, R., D’Angelo, G., Macy, E., Xiong, C., Carter, D., Cairns, N.J., Fagan, A.M., Head, D., Mintun, M.A., Ladenson, J.H., Lee, J.M., Morris, J.C., & Holtzman, D.M. Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Annals of Neurology 2011; 70: 274-285. PMC3154071
Name: Anne Fagan
Year: 2011
Reference:
Wang L, Fagan AM, Shah AR, Beg MF, Csernansky JG, Morris JC, Holtzman DM. Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders, 2011 Dec 7. PMCID: PMC3309103
Name: Lisa Taylor-Reinwald
Year: 2011
Reference:
Weiner, M.W., Veitch, D.P., Aisen, P.S., Beckett, L.A., Cairns, N.J., Green, R.C., Harvey, D., Jack, C.R., Jagust, W., Liu, E., Morris, J.C., Petersen, R.C., Saykin, A.J., Schmidt, M.E., Shaw, L., Siuciak, J.A., Soares, H., Toga, A.W., Trojanowski, J.Q. & the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimer’s and Dementia 2011 (in press).
Name: alison goate
Year: 2011
Reference:
Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, Lee JH, Bird TD, Bennett DA, Diaz-Arrastia R, Goate AM, Farlow M, Ghetti B, Sweet RA, Foroud TM, Mayeux R; NIA-LOAD/NCRAD Family Study Group. Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 2011, 7(2):e1001308. PMCID: 3040659
Name: Anne Fagan
Year: 2011
Reference:
Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, Morris JC. Role of family history for Alzheimer biomarker abnormalities in the Adult Children Study. Archives of Neurology 2011 Oct;68(10):1313-9. PMCID: PMC3327304
Name: David Balota
Year: 2011
Reference:
Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Morris JC. Role of family history for Alzheimer biomarker abnormalities in the Adult Children Study. Archives Of Neurology 2011; 68(10): 1313-1319. PMCID: PMC3327304.
Name: Lisa Taylor-Reinwald
Year: 2011
Reference:
Zhu, L., Cairns, N.J., Tabbal, S.D., & Racette, B.A. Pregnancy in multiple system atrophy: a case report. Journal of Medical Case Reports 2011; 5: 599. PMC3261365
Name: David Carr
Year: 2010
Reference:
45. Carr David B, Ott Brian R. The Older Driver with Cognitive Impairment “It’s A Very Frustrating Lifeâ€. JAMA 2010 Apr 28;303(16):1632-41. (PMCID: PMC2915446)
Name: Anne Fagan
Year: 2010
Reference:
Ances BM, Christensen JJ, Teshome M, Taylor J, Xiong C, Aldea P, Fagan AM, Holtzman DM, Morris JC, Mintun MA, Clifford DB. Cognitively unimpaired HIV+ participants do not have increased 11C-PiB: A case control study. Neurology, 2010; 75:111-115. PMCID: PMC2905926
Name: Randall Bateman
Year: 2010
Reference:
Cook JJ, Wildsmith KR, Gilberto DB, Holahan MA, Kinney GG, Mathers PD, Michener MS, Price EA, Shearman MS, Simon AJ, Wang JX, Wu G, Yarasheski KE, Bateman RJ. Acute Gamma-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid- Production to Alternative APP Fragments without Amyloid-Beta Rebound. J Neurosci. 2010 May 12;30(19):6743-50. PMID: 20463236
Name: Anne Fagan
Year: 2010
Reference:
Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D’Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM. YKL-40: A novel prognostic fluid biomarker for preclinical Alzheimer’s disease. Biological Psychiatry, 2010; 68:903-12. PMCID: PMC3011944
Name: Alison Goate
Year: 2010
Reference:
Cruchaga C, Kauwe JS, Mayo K, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Peskind E, the Alzheimer’s Disease Neuroimaging Initiative, Morris JC, Fagan AM, Holtzman DM, and Goate A. SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer’s Disease. 2010; 6(9). PMCID: 2940763
Name: Anne Fagan
Year: 2010
Reference:
Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, Peskind ER, Li G, Leverenz JB, Galasko D; Alzheimer’s Disease Neuroimaging Initiative, Morris JC, Fagan AM, Holtzman DM, Goate AM. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer’s disease. PLoS Genetics, 2010; Sep 16;6(9). PMCID: PMC2940763
Name: Anne Fagan
Year: 2010
Reference:
Fagan AM and Holtzman DM. CSF biomarkers of Alzheimer’s disease. Biomarkers in Medicine, 2010; 4:51-63. PMCID: PMC2846664
Name: Anne Fagan
Year: 2010
Reference:
Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC. Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain 2010; 133:3290-3300. PMCID: PMC2965421